Cite
MLA Citation
Andrew Aw and Jennifer R. Brown. “The potential combination of BCL-2 inhibitors and ibrutinib as frontline therapy in chronic lymphocytic leukemia.” Leukemia & lymphoma, vol. 58, no. 10, 2017, pp. 2287–2297. http://access.bl.uk/ark:/81055/vdc_100109756936.0x00002f